Tagmaster is showing continued progress in Q1 with good top-line growth, double digit EBITDA margins...
Redeye has updated its forecasts and valuation following Modelon’s Q1 2026 report, which came in bel...
* Soft sales mostly on FX and order timing * We cut '26e-'27e adj.
* Muted sales more than offset by margin expansion * Limited estimate changes on market uncertaintie...
With reported numbers well in line with our estimates, Inderes’ Q1 leaves us cautiously positive.
Leaddesk again delivered solid underlying profitability in Q1 despite a muted top line.
Moberg Pharma and Karo Healthcare have announced an expansion of their licensing agreement for MOB-0...
Adtraction redovisade ökad nettoomsättning och EBITA i det första kvartalet.
Actic’s Q1 report was solid, in our view, showcasing stronger ARPM than we had anticipated, despite ...
ByggPartner Gruppen levererade ett starkt kvartal med resultat över förväntan.
Teknikbolaget FreetraileFreetrailer utmanar traditionell släputhyrning med en appbaserad och kapital...
Redeye is optimistic about the full results from ATLAS-IT-05.
DT’s Q1 revenue was slightly higher than we estimated, while EBITA was in line.
Tekova’s Q1 results exceeded expectations, reinforcing confidence that operating profit will land in...
Redeye gives a short comment on the directed issue in Ascelia.
Redeye is encouraged to see Tagmaster presenting strong numbers across the board.
* Sales +1%, EBITA adj. +13% vs. FactSet consensus * Strong organic growth, but adj.
* Adj. EBIT well above estimates at SEK 45m * Underlying performance strong, but keep an eye out for...
Redeye provides its initial take on Heliospectra’s Q1 2026 results.
AVTECH's Q1 2026 report confirmed last week's pre-announced figures without adding material new info...
